Editor's Choice Articles are selected based on suggestions from Cancers’ Academic Editors worldwide. The Editors select a small number of recently published articles that they consider particularly interesting to our readers or important in their respective fields of research. You are welcome to read the Editor's Choice Articles and Special Issues related to cancer epidemiology and prevention, a curated list of high-quality articles from 2022 to 2023 in Cancers (ISSN: 2072-6694). The full list of Editor's Choice Articles can be viewed at the following link: https://www.mdpi.com/journal/cancers/editors_choice. The list of relevant papers can be seen below.

“Proton Pump Inhibitor Use and Risk of Gastric Cancer: Current Evidence from Epidemiological Studies and Critical Appraisal”
by Tahmina Nasrin Poly, Ming-Chin Lin, Shabbir Syed-Abdul, Chih-Wei Huang, Hsuan-Chia Yang andYu-Chuan (Jack) Li
Cancers 2022, 14(13), 3052; https://doi.org/10.3390/cancers14133052
Available online: https://www.mdpi.com/2072-6694/14/13/3052

“The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy”
by Niklas Sturm, Thomas J. Ettrich and Lukas Perkhofer
Cancers 2022, 14(1), 217; https://doi.org/10.3390/cancers14010217
Available online: https://www.mdpi.com/2072-6694/14/1/217

“Exosomal Proteins and Lipids as Potential Biomarkers for Lung Cancer Diagnosis, Prognosis, and Treatment”
by Ming-Tsung Hsu, Yu-Ke Wang and Yufeng Jane Tseng
Cancers 2022, 14(3), 732; https://doi.org/10.3390/cancers14030732
Available online: https://www.mdpi.com/2072-6694/14/3/732

“Update on Epidemiology, Diagnosis, and Biomarkers in Gastroenteropancreatic Neuroendocrine Neoplasms”
by Daisuke Takayanagi, Hourin Cho, Erika Machida, Atsushi Kawamura, Atsuo Takashima, Satoshi Wada, Takuya Tsunoda, Takashi Kohno and Kouya Shiraishi
Cancers 2022, 14(5), 1119; https://doi.org/10.3390/cancers14051119
Available online: https://www.mdpi.com/2072-6694/14/5/1119

“Hepatocellular Carcinoma: Surveillance, Diagnosis, Evaluation and Management”
by Jessica Elderkin, Najeeb Al Hallak, Asfar S. Azmi, Hussein Aoun, Jeffrey Critchfield, Miguel Tobon and Eliza W. Beal
Cancers 2023, 15(21), 5118; https://doi.org/10.3390/cancers15215118
Available online: https://www.mdpi.com/2072-6694/15/21/5118

“Elevated Glycated Haemoglobin (HbA1c) Is Associated with an Increased Risk of Pancreatic Ductal Adenocarcinoma: A UK Biobank Cohort Study”
by Declan McDonnell, Adrian W. E. Cheang, Sam Wilding, Sarah H. Wild, Adam E. Frampton, Christopher D. Byrne and Zaed Z. Hamady
Cancers 2023, 15(16), 4078; https://doi.org/10.3390/cancers15164078
Available online: https://www.mdpi.com/2072-6694/15/16/4078

“Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence”
by Vincenza Granata, Roberta Fusco, Sergio Venanzio Setola, Roberta Galdiero, Nicola Maggialetti, Lucrezia Silvestro, Mario De Bellis, Elena Di Girolamo, Giulia Grazzini, Giuditta Chiti et al.
Cancers 2023, 15(2), 351; https://doi.org/10.3390/cancers15020351
Available online: https://www.mdpi.com/2072-6694/15/2/351

“Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKI”
by John Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, Ching-Fu Chang, Cheng-Ta Yang, Chih-Hsi Scott Kuo, Ping-Chih Hsu and Chiao-En Wu
Cancers 2022, 14(4), 977; https://doi.org/10.3390/cancers14040977
Available online: https://www.mdpi.com/2072-6694/14/4/977

“Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study”
by Junjie Huang, Wing Chung Chan, Chun Ho Ngai, Veeleah Lok, Lin Zhang, Don Eliseo Lucero-Prisno III, Wanghong Xu, Zhi-Jie Zheng, Edmar Elcarte, Mellissa Withers et al.
Cancers 2022, 14(9), 2230; https://doi.org/10.3390/cancers14092230
Available online: https://www.mdpi.com/2072-6694/14/9/2230

“Mathematical Model of Clonal Evolution Proposes a Personalised Multi-Modal Therapy for High-Risk Neuroblastoma”
by Matteo Italia, Kenneth Y. Wertheim, Sabine Taschner-Mandl, Dawn Walker and Fabio Dercole
Cancers 2023, 15(7), 1986; https://doi.org/10.3390/cancers15071986
Available online: https://www.mdpi.com/2072-6694/15/7/1986

“Breast Cancer—Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature)”
by Beata Smolarz, Anna Zadrożna Nowak and Hanna Romanowicz
Cancers 2022, 14(10), 2569; https://doi.org/10.3390/cancers14102569
Available online: https://www.mdpi.com/2072-6694/14/10/2569

“BRAF and MEK Inhibitors and Their Toxicities: A Meta-Analysis”
by Mattia Garutti, Melissa Bergnach, Jerry Polesel, Lorenza Palmero, Maria Antonietta Pizzichetta and Fabio Puglisi
Cancers 2023, 15(1), 141; https://doi.org/10.3390/cancers15010141
Available online: https://www.mdpi.com/2072-6694/15/1/141

“Sex Differences in the Efficacy of Immune Checkpoint Inhibitors in Neoadjuvant Therapy of Non-Small Cell Lung Cancer: A Meta-Analysis”
by Guillermo Suay, Juan-Carlos Garcia-Cañaveras, Francisco Aparisi, Agustin Lahoz and Oscar Juan-Vidal
Cancers 2023, 15(18), 4433; https://doi.org/10.3390/cancers15184433
Available online: https://www.mdpi.com/2072-6694/15/18/4433

Special Issues:
“Oral Cancer: Prevention and Early Detection”
Guest Editors: Prof. Dr. Umberto Romeo and Dr. Gianluca Tenore
Submission deadline: 31 August 2024

“Skin Cancer: Risk Factors and Prevention”
Guest Editors: Dr. Feras M. Ghazawi, Dr. Ivan V. Litvinov and Prof. Dr. Robert Gniadecki
Submission deadline: 30 November 2024

You are invited to view and submit relevant papers to the journal Cancers at the following link:

https://www.mdpi.com/journal/cancers.

Cancers Editorial Office